What is a compounding pharmacy?

A compounding pharmacy is a state-licensed pharmacy that prepares customized medications from raw pharmaceutical ingredients, rather than dispensing commercially manufactured products. Compounding is used when a patient needs a strength, formulation, or delivery route that is not commercially available.

Why is ketamine often dispensed by compounding pharmacies?

Commercially manufactured ketamine is only available as an injectable solution and as the Spravato nasal spray. Sublingual troches, oral lozenges, intranasal sprays in custom concentrations, and rectal formulations all require compounding because no FDA-approved off-the-shelf product exists for those routes.

What is the difference between a 503A and 503B compounding pharmacy?

A 503A pharmacy compounds patient-specific prescriptions one at a time under state board oversight. A 503B outsourcing facility manufactures larger batches without patient-specific prescriptions and is FDA-registered with stricter quality requirements. Both can supply ketamine, but the regulatory pathway and quality controls differ.

How can a patient verify that a compounding pharmacy is legitimate?

Patients can confirm the pharmacy's license through the state board of pharmacy and check for PCAB (Pharmacy Compounding Accreditation Board) accreditation, which is voluntary but signals adherence to higher quality standards. Reputable compounders disclose their sterility testing, beyond-use dates, and ingredient sources on request.

Are compounded ketamine prescriptions covered by insurance?

Coverage is rare. Most commercial insurers and Medicare exclude compounded ketamine because it is used off-label for depression and lacks FDA approval for that indication. Patients typically pay out of pocket, with sublingual troche regimens generally falling in the $100-$300 per month range.

Compounded Ketamine: Pharmacy Guide

Quick Answer

A compounding pharmacy creates customized medications from raw pharmaceutical ingredients based on a clinician's prescription. In ketamine therapy, compounding pharmacies are the source of oral tablets, sublingual troches, rapid-dissolve tablets, and nasal sprays, none of which are sold as commercial products.

What is compounded ketamine?

Compounded ketamine is ketamine prepared by a licensed compounding pharmacy into a customized form - typically sublingual tablets, troches, rapid-dissolve tablets, or nasal sprays - in a specific milligram strength prescribed by a clinician. It is distinct from FDA-approved injectable ketamine and from branded esketamine (Spravato).

What does "compound ketamine" or a custom medication formulation mean?

Compounding combines active pharmaceutical ingredients with inactive excipients to produce a finished medication tailored to one patient. For ketamine, that lets prescribers fine-tune dose strength, flavor, and delivery route (for example, a 50 mg or 100 mg sublingual tablet) that does not exist as an off-the-shelf product.

Are compounded ketamine formulations FDA-approved?

Individual compounded preparations are not FDA-approved as finished products; the FDA approves the active ingredient and oversees the compounding pharmacy's licensing and good practices. Quality therefore depends heavily on choosing a pharmacy with strong sterility, potency testing, and state licensing.

What are typical custom pharmaceutical formulations of ketamine?

The most common compounded ketamine formulations are sublingual troches and rapid-dissolve tablets in the 50-200 mg range, intranasal sprays delivering 10-50 mg per spray, and oral capsules. Topical creams for neuropathic pain are produced by some pharmacies as well, though they fall outside mental-health protocols.

Definition

A compounding pharmacy is a licensed pharmacy that prepares customized medications tailored to individual patient needs. Unlike conventional pharmacies that dispense commercially manufactured drugs in standardized forms and doses, compounding pharmacies create medications from raw pharmaceutical ingredients according to a prescriber's specific instructions. In the context of ketamine therapy, compounding pharmacies are the primary source of oral tablets, sublingual troches, rapid-dissolve tablets, nasal sprays, and topical creams — formulations that are not available as commercially manufactured products.

How Compounding Works

Compounding pharmacists combine active pharmaceutical ingredients (APIs) with excipients — inactive ingredients such as binders, flavorings, and preservatives — to create a finished medication in the form, dose, and delivery method specified by the prescribing clinician. For more on what patients should know about compounded medications, see our compounding pharmacy guide. For ketamine, this process typically involves:

Sourcing pharmaceutical-grade racemic ketamine powder from FDA-registered suppliers
Precisely measuring the prescribed dose using calibrated analytical balances
Combining the ketamine with appropriate excipients for the desired dosage form
Performing quality checks to verify potency, uniformity, and sterility (when applicable)
Packaging and labeling the finished product with complete prescription information

Common compounded ketamine formulations include sublingual troches (lozenges designed to dissolve under the tongue), rapid-dissolve tablets, oral solutions, nasal spray preparations, and topical creams for pain management.

Regulatory Framework

Compounding pharmacies operate under a distinct regulatory framework from commercial drug manufacturers. Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies that prepare medications in response to individual prescriptions. Section 503B governs outsourcing facilities — larger-scale operations that may compound drugs in anticipation of prescriptions without patient-specific orders.

Key regulatory requirements include:

State licensing: Every compounding pharmacy must hold a valid state pharmacy license and comply with state board of pharmacy regulations, which vary by jurisdiction.
USP standards: Compounded preparations must meet United States Pharmacopeia (USP) standards for quality, including USP <795> for non-sterile compounding and USP <797> for sterile preparations.
Prescription requirement: Under Section 503A, compounded medications may only be prepared in response to a valid patient-specific prescription from a licensed prescriber.
DEA compliance: Because ketamine is a Schedule III controlled substance, compounding pharmacies must hold a DEA registration, maintain detailed dispensing records, and comply with all applicable controlled substance regulations.

Role in Ketamine Treatment

Compounding pharmacies are indispensable to the current ketamine treatment landscape for several reasons:

Formulation flexibility: The only FDA-approved ketamine-based product for depression is the esketamine nasal spray. All other ketamine formulations used for psychiatric treatment — including the widely prescribed sublingual troches used in at-home programs — are compounded. Without compounding pharmacies, these treatment options would not exist.

Dose customization: Clinicians can prescribe exact doses tailored to each patient's weight, tolerance, and clinical response. This is particularly valuable for ketamine, where optimal dosing varies significantly between individuals and may require fine-tuned adjustments over the course of treatment.

Cost accessibility: Compounded ketamine formulations are typically far less expensive than the branded esketamine product, which can cost over $500 per treatment session before insurance. Compounded troches or tablets may cost a fraction of that amount, making ketamine therapy financially accessible to a broader patient population.

Route of administration options: Not all patients can tolerate or access IV infusion clinics. Compounded oral and sublingual formulations enable at-home treatment under clinical supervision, significantly expanding access to ketamine therapy.

Quality Considerations

Because compounded medications are not subject to the same FDA approval process as commercially manufactured drugs, quality assurance depends heavily on the individual pharmacy's practices, equipment, and oversight. Patients and providers should consider:

Whether the pharmacy holds accreditation from organizations such as the Pharmacy Compounding Accreditation Board (PCAB)
The pharmacy's track record with state board of pharmacy inspections
Whether the pharmacy conducts third-party potency and purity testing on its compounded products
The pharmacy's compliance with current USP compounding standards

References

FDA Information on Drug Compounding — Official FDA resource on compounding regulations and safety.
USP Compounding Standards — United States Pharmacopeia compounding quality standards.
Section 503A and 503B of the FD&C Act — Federal statutory framework for compounding pharmacies.
NABP Compounding Resources — National Association of Boards of Pharmacy compounding oversight information.

Compounding Pharmacy: Custom Ketamine Formulations Explained

Frequently Asked Questions